Atlas Trials

Real-World Study of Toripalimab in Extensive-Stage Small Cell Lung Cancer

Clinical trial NCT07308379 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07308379
Sponsor
Fudan University
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
SCLC, Extensive StageToripalimab
Start date
2026-02-01
Primary completion
2028-02-01
Enrollment
1200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.